MeSH term
Count | Erythropoietin/adverse effects/blood/*therapeutic use | 5 |
Erythropoietin/*adverse effects/therapeutic use | 3 |
Erythropoietin/adverse effects/*therapeutic use | 11 |
Erythropoietin/adverse effects/chemistry/*therapeutic use | 1 |
Erythropoietin, Recombinant/adverse effects/therapeutic use | 1 |
Erythropoietin/adverse effects/*economics/therapeutic use | 1 |
Erythropoietin, Recombinant/adverse effects/*therapeutic use | 4 |
Erythropoietin/adverse effects/pharmacokinetics/*therapeutic use | 1 |
Erythropoietin/adverse effects/pharmacology/*therapeutic use | 1 |
Erythropoietin/adverse effects/physiology/*therapeutic use | 1 |
Erythropoietin, Recombinant/*adverse effects/therapeutic use | 1 |
Erythropoietin, Recombinant/*adverse effects/economics/therapeutic use | 1 |
Erythropoietin/*adverse effects/blood/genetics | 1 |
Erythropoietin/administration & dosage/*adverse effects/*blood | 1 |
Erythropoietin/*adverse effects | 5 |
Erythropoietin/adverse effects/*pharmacology | 1 |
Erythropoietin, Recombinant/*adverse effects | 4 |
Erythropoietin, Recombinant/*adverse effects/*immunology | 1 |
Erythropoietin/*administration & dosage/adverse effects | 2 |
Erythropoietin, Recombinant/adverse effects/*pharmacology | 1 |
Erythropoietin/administration & dosage/*adverse effects | 2 |
Erythropoietin/adverse effects/*genetics/metabolism/pharmacology | 1 |
Erythropoietin, Recombinant/administration & dosage/adverse effects | 1 |
Erythropoietin, Recombinant/*administration & dosage/adverse effects | 2 |
Erythropoietin/*administration & dosage/adverse effects/pharmacology | 1 |
Erythropoietin/*blood/*therapeutic use | 5 |
Erythropoietin/blood/*therapeutic use | 10 |
Erythropoietin/blood/therapeutic use | 3 |
Erythropoietin/*blood/therapeutic use | 8 |
Erythropoietin/blood/*deficiency/*therapeutic use | 1 |
Erythropoietin/blood/metabolism/therapeutic use | 1 |
Erythropoietin/biosynthesis/*blood/therapeutic use | 1 |
Erythropoietin/blood/deficiency/*therapeutic use | 2 |
Erythropoietin/biosynthesis/blood/therapeutic use | 1 |
Erythropoietin, Recombinant/blood/*therapeutic use | 1 |
Erythropoietin/*blood/genetics/therapeutic use | 1 |
Erythropoietin/blood/immunology/*therapeutic use | 1 |
Erythropoietin/*administration & dosage/blood/therapeutic use | 2 |
Erythropoietin/blood/genetics/secretion/*therapeutic use | 1 |
Erythropoietin/administration & dosage/blood/therapeutic use | 1 |
Erythropoietin/administration & dosage/blood/*therapeutic use | 3 |
Erythropoietin/administration & dosage/*blood/therapeutic use | 1 |
Erythropoietin/administration & dosage/*blood/chemistry/therapeutic use | 1 |
Benzophenones/adverse effects/blood/*therapeutic use | 1 |
Thyrotropin/adverse effects/blood/*therapeutic use | 1 |
Azathioprine/adverse effects/blood/therapeutic use | 1 |
Thalidomide/adverse effects/blood/*therapeutic use | 1 |
Chlorpromazine/adverse effects/*blood/therapeutic use | 1 |
Cyclosporine/adverse effects/blood/therapeutic use | 1 |
Carbamazepine/*adverse effects/blood/therapeutic use | 1 |
Propoxyphene/*adverse effects/blood/therapeutic use | 1 |
Piperidines/*adverse effects/blood/therapeutic use | 1 |
Lipoproteins/adverse effects/blood/*therapeutic use | 1 |
Dehydroepiandrosterone/adverse effects/blood/*therapeutic use | 1 |
Cyclosporine/adverse effects/*blood/therapeutic use | 1 |
Interleukin-2/adverse effects/blood/*therapeutic use | 1 |
Immunoglobulin G/adverse effects/blood/*therapeutic use | 1 |
Cyclosporine/adverse effects/*blood/*therapeutic use | 2 |
Clofibrate/*adverse effects/blood/therapeutic use | 1 |
Pyridines/adverse effects/blood/*therapeutic use | 2 |
Swainsonine/adverse effects/blood/*therapeutic use | 1 |
Oxazines/adverse effects/*blood/therapeutic use | 1 |
Interleukin-6/adverse effects/blood/*therapeutic use | 1 |
Bezafibrate/adverse effects/blood/*therapeutic use | 1 |
Ribavirin/adverse effects/blood/*therapeutic use | 1 |
Anticonvulsants/*adverse effects/blood/therapeutic use | 1 |
Immunoglobulins, Fab/adverse effects/blood/*therapeutic use | 1 |
Rifabutin/adverse effects/*blood/therapeutic use | 1 |
Enterotoxins/adverse effects/blood/*therapeutic use | 1 |
Magnesium/adverse effects/blood/*therapeutic use | 1 |
Fluphenazine/adverse effects/blood/*therapeutic use | 1 |
Pimozide/adverse effects/blood/*therapeutic use | 1 |
Immunoglobulin A/adverse effects/blood/*therapeutic use | 1 |
Ritonavir/adverse effects/blood/*therapeutic use | 1 |
Enalapril/adverse effects/blood/*therapeutic use | 1 |
Citalopram/adverse effects/blood/*therapeutic use | 1 |
Fluvoxamine/adverse effects/blood/*therapeutic use | 1 |
Saquinavir/adverse effects/blood/*therapeutic use | 1 |
*Immunoglobulin G/adverse effects/blood/therapeutic use | 1 |
Metformin/adverse effects/blood/*therapeutic use | 1 |
Testosterone/adverse effects/blood/*therapeutic use | 1 |
Thyroxine/*adverse effects/blood/therapeutic use | 1 |
Didanosine/adverse effects/blood/*therapeutic use | 1 |
Dipeptides/adverse effects/blood/*therapeutic use | 1 |
Zidovudine/adverse effects/blood/*therapeutic use | 1 |
Growth Hormone/*adverse effects/blood/therapeutic use | 1 |
Antiparkinson Agents/*adverse effects/blood/*therapeutic use | 1 |
Anti-HIV Agents/adverse effects/*blood/therapeutic use | 2 |
Antidepressive Agents/adverse effects/blood/*therapeutic use | 1 |
Enzyme Inhibitors/adverse effects/blood/*therapeutic use | 1 |
Immunosuppressive Agents/adverse effects/*blood/*therapeutic use | 2 |
Chimeric Proteins/adverse effects/blood/*therapeutic use | 1 |
Immunosuppressive Agents/adverse effects/blood/therapeutic use | 2 |
Anti-HIV Agents/*adverse effects/blood/therapeutic use | 1 |
Recombinant Proteins/adverse effects/blood/therapeutic use | 3 |
Antibodies, Monoclonal/adverse effects/blood/*therapeutic use | 2 |
Quinazolines/adverse effects/blood/pharmacokinetics/*therapeutic use | 1 |
Peptide Fragments/*adverse effects/blood/therapeutic use | 1 |
HIV Protease Inhibitors/adverse effects/blood/*therapeutic use | 1 |
Anti-HIV Agents/adverse effects/blood/*therapeutic use | 1 |
